ACNNF
Price:
$0.0038
Market Cap:
$2.55M
AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-02-10
Stock Exchange
PNK
Ticker
ACNNF
According to AusCann Group Holdings Ltd’s latest financial reports and current stock price. The company's current ROE is -96.80%. This represents a change of 624.48% compared to the average of -13.36% of the last 4 quarters.
The mean historical ROE of AusCann Group Holdings Ltd over the last ten years is -90.28%. The current -96.80% ROE has changed 7.23% with respect to the historical average. Over the past ten years (40 quarters), ACNNF's ROE was at its highest in in the June 2010 quarter at 0%. The ROE was at its lowest in in the June 2016 quarter at -887.05%.
Average
-90.28%
Median
-87.86%
Minimum
-203.92%
Maximum
-18.36%
Discovering the peaks and valleys of AusCann Group Holdings Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 646.44%
Maximum Annual ROE = -18.36%
Minimum Annual Increase = -66.22%
Minimum Annual ROE = -203.92%
Year | ROE | Change |
---|---|---|
2023 | -150.60% | 3.73% |
2022 | -145.19% | 646.44% |
2021 | -19.45% | -4.80% |
2020 | -20.43% | 11.29% |
2019 | -18.36% | -66.22% |
2018 | -54.34% | -40.71% |
2017 | -91.64% | -55.06% |
2016 | -203.92% | 142.51% |
2015 | -84.09% | -26.72% |
2014 | -114.74% | 276.85% |
The current ROE of AusCann Group Holdings Ltd (ACNNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-105.08%
5-year avg
-70.80%
10-year avg
-90.28%
AusCann Group Holdings Ltd’s ROE is less than Amexdrug Corporation (0.09%), less than Aion Therapeutic Inc. (60.85%), less than Aspen Pharmacare Holdings Limited (0.44%), greater than Antisense Therapeutics Limited (-109.43%), greater than Alterola Biotech, Inc. (-20.20%), greater than The BC Bud Corporation (-171.61%), greater than Crescita Therapeutics Inc. (-16.29%),
Company | ROE | Market cap |
---|---|---|
0.09% | $338.82K | |
60.85% | $2.39M | |
0.44% | $5.44B | |
-109.43% | $92.64M | |
-20.20% | $7.74M | |
-171.61% | $781.33K | |
-16.29% | $8.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AusCann Group Holdings Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AusCann Group Holdings Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is AusCann Group Holdings Ltd's ROE?
How is the ROE calculated for AusCann Group Holdings Ltd (ACNNF)?
What is the highest ROE for AusCann Group Holdings Ltd (ACNNF)?
What is the 3-year average ROE for AusCann Group Holdings Ltd (ACNNF)?
What is the 5-year average ROE for AusCann Group Holdings Ltd (ACNNF)?
How does the current ROE for AusCann Group Holdings Ltd (ACNNF) compare to its historical average?